A study in Britain which saw children with peanut allergies given ever-increasing doses of peanut flour has cured 12 children of their allergies. Photo / Getty Images
A study in Britain which saw children with peanut allergies given ever-increasing doses of peanut flour has cured 12 children of their allergies. Photo / Getty Images
KEY POINTS:
Allergy to peanuts may be curable following positive results from the world's first successful desensitisation programme for peanut allergy, scientists say.
Children who risked suffering anaphylactic shock, a potentially fatal reaction, if they encountered a single peanut have been protected so that they are able to eatwithout fear.
The finding will bring hope to thousands of families whose lives have been blighted by the allergy, one of the fastest growing in Britain.
It is estimated one in 50 young people are affected by peanut allergy and cases have more than doubled in four years.
The desensitisation programme at Addenbrooke's Hospital involved 22 children aged seven to 17, who were given tiny 5mg starting doses of peanut flour.
Gradually over six months the daily dose was built up to 800mgs a day, equivalent to five peanuts.
Twelve children have reached the highest dose level and can tolerate twice as much, equivalent to 10 peanuts, without suffering side effects.
For the first time their families know they can lead a normal life and be safe.
Andy Clark, who led the research, said: "Every time people with a peanut allergy eat something, they're frightened that it might kill them. Our motivation was to find a treatment that would change that and give them the confidence to eat what they like."
He added: "It's not a permanent cure but as long as they go on taking a daily dose they should maintain their tolerance."
All 12 children are keeping up their tolerance by taking the equivalent of up to five peanuts a day.
Dr Clark said: "At the moment we know that if they continue to eat five peanuts a day, their tolerance is maintained."
Dr Clark said the children would be followed for the next three or four years to monitor their tolerance levels and future studies would assess whether the dose could be given as a daily pill.
After three or four years, the body may have adjusted and there could be a more "permanent cure", he said.
Details of the first four patients are published in the journal Allergy.
Professor Pam Ewan, head of allergy at Addenbrooke's, who oversaw the research, said the technique had not been tried before because researchers had been afraid it was too dangerous.
